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130. Long term effects of time, pregnancy and 
medical treatment on plasma prolactin levels in 176 
hyperprolactinemic women 
A.M. Mattei, V. Cavioni, G. testa, A Zaro, and P.G. Crosignani 
III Department of Obstetrics and Gynaecology, University of 
Milano, Italy 
In order to show evidence of prolactin changes specifically 
related to drug use, pregnancy or the simple effect of time, the 
evolution of plasma prolactin (PRL) levels were studied in 176 
hyperprolactinemic women (87 carrying a prolactinoma) over a 
mean period of four years (range between 6-180 months). 
Clinical presentation of the patients was amenorrhea for 110 
oligomenorrhea for 37 while 29 had normal but anovulator; 
cycles. 
107 patients underwent 191 cycles of medical tretament (mean 
length 11 months; range 2-43), 73 got pregnant spontaneously or 
during drug intake while in 38 subjects spontaneous evolution of 
plasma prolactin concentration was evaluated over a mean period 
of 19 months (range 6-72). 
Evaluation of prolactin changes after medical treatment 
pregnancy or just waiting periods showed a significant lower 
mean PRL level only in the idiopathic group of patients after 
pregnancy. 
PRL trend of the individual values in both groups of patients 
indicate that: pregnancy normalizes prolactin concentration in 
49% of patients and medical therapy is linked with a 
normalization rate of 27%. 
131. Dose-dependent suppression of serum Prolactin 
by cabergoline in hyperprolactinemic patients: a 
placebo controlled, randomized, double blind multi-
centre study 
I. Webster l , M.F. Scalon1, A. D'Alberton, L. Falsetti, C. 
Ferrari, P. Fioretti, G. Giordano, M. L'Hermite, F. Camanni, 
P.G. Crosignani, L. De Cecco, R. Fadini, G. Faglia, F. 
Flamigni, and G. Tamburrano 
European Multicentre Study Group; 1 Neuroendocrine Unit, 
Department of Medicine, University of Wales, College of 
Medicine, Cardiff, Wales, United Kingdom 
Cabergoline is a novel dopamine agonist with very long-
lasting (7-14 days) Prolactin (PRL)-lowering activity after oral 
administration. We have investigated the efficacy and tolerability 
of a range of doses of cabergoline in suppressing Prolactin in 
hyperprolactanemic women. 
Patients and methods. This was a multi-centre, prospective, 
randomized, double-blind study involving 188 women with 
hyperprolactinemia secondary to a microprolactinoma (n=113, 
60.1%), ideopathic disease (n=67, 35.6%), empty sella syndrome 
(n=5, 2.7%), or following failed surgery for prolactinoma (n=3, 
1.6%). The mean age was 31.8 years (range 16-46). Patients 
received either placebo (n=20) or cabergoline 0.125 mg (n=43), 
0.5 mg (n=42), 0.75 mg (n=42) or 1 mg (n=41) twice weekly for 
four weeks, the first week's treatment being half dose; There were 
no significant differences in age, diagnosis r previous therapy 
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between the 5 treatment groups; mean (± SEM) pre-treatment 
prolactins were 65.0 ± 6.3, 90.8 ± 14.8, 92.7 ± 13.8, 129.0 ± 
20.1 and 70.0 ± 6.6 ng:ml respectively. 
Results; After 4 weeks treatment PRL was suppressed to 
below half the pre-treatment level in 5%,60%,90%,95% and 
98%, and completely normalized in 0%, 30%, 74%, and 95% of 
patients taking placebo or cabergoline (0.125 mg, 0.5 mg, 0.75 
mg and 1 mg twice weekly respectively, showing a dose-response 
relationship among cabergoline doses (Armitage test: p«0.01). 
In contrast, at these doses, adverse effects were reported in 45%, 
44%, 50% and 58% of patients with no evident dose relationship. 
Over 95% of reported side effects were relatively trivial, most 
frequently transient nausea, headache and dizziness. Severe adverse 
events including dizziness, nausea, headache and fatigue occurred 
in 13 patients taking cabergoline (7.7%) but treatment had to be 
discontinued in only one patient who experienced severe 
dizziness. 
Conclusions. Cabergoline is effective in normalizing PRL in 
hyperprolactinemia at doses of 0.5 - 1.0 mg twice weekly. Its 
tolerability and simple administration schedule represent a 
significant therapeutic advance in the management of 
hyperprolactinemia. 
132. Parlodel LAR in the chronic treatment of 
hyperprolactinaemic patients 
A. Pedroncelli, M. Montini, G. Pagani, M.D. Pagani, D. 
Gianola, F. Tengattini, L. Cortesi, F. Gherardi, F. Sileo, and I. 
Lancranjanl 
Department of Endocrinology, Neuroendocrine Unit, United 
Hospitals, Bergamo, Italy, and 1 Department of Neuro-
endocrinology, Clinical Research, Sandoz Pharma Ltd, Basel, 
Switzerland 
Parlodel LAR, a new injectable long-acting form of 
bromocriptine, was administered to 78 patients (63 women and 
15 men) affected by prolactinomas. At the CT-Scan/NMR 
macroadenoma was present in 31n8 patients (pts). The initial 
dose of Pardlodel LAR was 25mg in 8 pts, 50mg in 62 and 
l00mg in the other 8 pts. AU pts received repeated injections of 
Parlodel LAR at the dose of 25-200mg every 28-60 days for 3-48 
months. In every patient clinical evaluation, PRL plasma levels, 
tumor size evaluation and visual field (VF) examination were 
monitored. A marked decrease in PRL plasma levels was achieved 
in all patients whereas PRL normalization in 45n8 pts after the 
first injection of Parlodel LAR. Eighteen of 78 pts also had 
bromocriptin plasma levels assessed after the first injection of 
Parlodel LAR 25mg, 50mg or 100mg (6 pts/dose) to assess the 
dose proportionality of this injectable bromocriptin preparation. 
Fifteen of 18 pts ,ormalized PRL plasma levels independently of 
the dose. The duration of PRL suppression/normalization lasted 7 
to 60 days with a positive correlation between the length of 
efficacy and the initial dose used. At the CT -Scan/NMR a marked 
tumor shrinkage (20-60%) was observed in 19/31 pts with 
macroprolactinoma within the first 28 days after the first dose of 
Parlodel LAR 50mg. After 6-12 month's therapy complete 
disappearance of the pituitary tumor was documented in 3/31 pts. 
Three of the 4 pts who had VF defects obtained a complete and 
quick normalization of their VF within 12-72 hours after the first 
injection of Parlodel LAR. The clinical symptoms/signs recorded 
in 72(18 pts regressed in 69n2 pts after 14-700 days treatment. 
No important side effects were reported except in 2 cases. 
Patients' compliance was very good due to the therapeutic 
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efficacy, good tolerability and long-lasting action of Parlodel The use of an urinary LH rapid assay seems effective in 
LAR. Therefore, in conclusion, Parlodel LAR could be considered raising the pregnancy rate of CC therapy in infertile patients. 
the frrst choice treatment in pts with prolactinoma. 
135. Cumulative pregnancy rates after LHRH· 
133. Menses alteration in relationship to various treatment in hypothalamic amenorrhea 
precentage of weight loss 
D.D.M. Braat and J. Schoemaker 
E. Pasinetti, L. Falsetti, and A. Gastaldi Academic Hospital of the "Vrije Universiteit", Amsterdam, The 
Department of Obstetrics and Gynaecology, University of Netherlands 
Brescia, Italy 
We have evaluated the clinical and hormonal profile 203 of 
women, aged 18 to 26 years, who in hte last year had suffered a 
loss of wieght of 10-14% (group A), of 15·20% (group B) and 
more 20% (group C) in comparison with their intial weight. The 
frequency of amenorrhea and regular cycles was found to be 
greatly influenced by weight loss: in group A we saw amenorrhea 
in 75.3% of cases and regular cycles in 24.7%; in group B we 
saw amenorrhea in 87.2% of cases and regular cycles in 12.8%; 
in group C amenorrhea was present in 95.2% of cases and regular 
cycles in 4.8%. 
Amonst those women with regular menses, all included in 
groups A and B, there was a major incidence of luteal phase defect 
(34.8% in A; 16.7% in B) showing variations in the secretion of 
gonadotropin-realising hormone (GnRH) and in the luteinizing 
hormone (LH) peak, caused by the former. 
The presence of a certain percentage of regular cycles 
including those in groups with a greater weight loss, demonstrate 
various responses to stress. 
The endocrinal evaluation showed in amenorrheic women a 
gradual decrease in the blood levels of gonadotrophin and 
estradiol, in groups A and C. In groups A and B, even though we 
can note apparently normal plasmatic levels of luteinizing 
hormone, the hypoestrogenism and the high percentage of 
amenorrhea confirm that in cases of minor weight loss there 
exists a modification in the pulsatile secretion of GnRH and 
gonadotropin. In addition the mean plasma cortisol levels were 
significantly increased whereas the prolactin levels were lower 
than controls. 
134. Effectiveness of urinary LH rapid assay in 
infertile women treated with clomiphene citrate 
M. Bertazzoli Grabinski Broglio, S. Simionato, M. Lucianetti, 
A. Miragoli 
Clinica Ostetrica Ginecologica II, Universita di Milano, Milan, 
Italy 
Thirteen infertile patients (ages 25 - 40) previously submitted 
to Clomiphene Citrate (CC) therapy unsuccessfully, were treated 
again by CC at the same dose during 17 monitored cycles. Eight 
patients were affected by primary infertility while 3 had 
undergone a spontaneous abortion early in the pregnancy and 2 
had a history of recurrent abortion. All patients had been 
evaluated by hysterosalpingography and/or laparoscopy without 
evidence of any abnormality. All CC cycles were controlled by 
intensive hormonal and ultrasound monitoring. When the 
dominant follicle diameter reached 14 mm. urinary LH rapid assay 
was effected every twelve hours (at 8 am and 8 pm) up to 
ovulatory surge evidence. Five patients underwent uneventful 
pregnancy while 2 did not conceive probably because husbands' 
semen analyses showed severe oligo-asthenospermia. 
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In 49 patients with hypothalamic amenorrhea 272 LHRH induced 
cycles were studied retrospectively. Pulse dose varied from 2 -
100 ~g/pulse; most patients received 10 or 20 ~g. No difference 
in ovulation and conception rate was found between 10 and 20 
ugram pulse dose cycles. Cumulative pregnancy rates (CPR) were 
calculated using the life table method. Forty-eight patients had 
244 ovulatory cycles of which 55 resulted in pregnancy; the CPR 
was 78% after 6 and 93% after 12 ovulatory cycles. Eight 
pregnancies (= 14.5%) ended in abortion, 5 pregnancies were 
multiple (4 twins, I triplet). 
Subdivisions of patients were made with respect to the presence 
of additional infertility factors, history of weight-loss, actual 
weight, estrogenic status and primary versus secondary 
amenorrhea. Evaluation of only first treatments per patients 
revealed a significant higher CPR in patients without other 
infertility factors compared to those with other factors (84% 
versus 60% after 6 cycles) (p < 0.05). No differences were found 
in life table curves of the other subdivisions. 
Using life-table statistics our data confrrm the general opinion 
that LHRH therapy is highly successful in patients with 
hypothalamic amenorrhea, especially if no other infertility factors 
arepresenL 
136. CHncal study of a new triphasic oral 
contraceptive (SH D 415 G, Milvane) in insulin 
dependent diabetic patients 
A. Pedroncelli, N. Mazzocchi, F. Tengattini, G. Lepore, L. 
Cortesi, M. Montini, D. Gianola, M.D. Pagani, and G. Pagani 
Department of Endorcinology, Diabetes Unit, United Hospitals, 
Bergamo, Italy 
A new triphasic oral contraceptive (SH D 415 G, Milvane) 
was studied in 14 insulin-dependent diabetic (IDDM) women, 
aged 27 - 39. IDDM was diagnosed 1.5-19 years ago. All the 
patients were on monocomponent human insulin adminstered 
twice a day in the form of preformed mixture (Actraphane®) at a 
variable dose of 26-52 U/day. No patients presented with 
overweight higher than 10% of the ideal body weight (ffiW). The 
metabolic parameters indicating glyco-metabolic balance (daily 
blood glucose curve, HbAIC, frutosamine, lipid profile, plasma 
uric acid), were within the normal range. Micro-albuminuria was 
recorded in 6/14 women, whereas glycosuria in 11/14 women and 
the latter was below 20 g/24 hours. All the patients were put on 
Milvane due to anticonceptional purposes and they were treated 
for at least 6 months without discontinuing the drug because of 
poor tolerance. Ovulation which was recorded in every patient 
was completely inhibited. The daily insulin requirement increased 
in all patients (from 4 to 8 U/day) without statistical 
significantly change in blood glucose profile, HbAIC and body 
weight. In the past 7/14 women had to discontinue other oral 
contraceptives due to the worsening of the glycometabolic 
balance. On the contrary, all the patients are still on Milvane. In 
conclusion, the anticonceptyional treatment with Milvane is not 
hithetto resulted to be able to worsen the metabolic balance in 
diabetic patients. Further studies are required during more 
prolonged treatment to dmw any definitive conclusions. 
137. Predictive value of tbe active renin assay for 
tbe early diagnosis of ectopic pregnancy 
L. Cedard, Th.M. Mignot, K. Meunier, A. Maria1, A Guichard, 
P. Boyer, I.R. Zorn 
U. 166 INSERM and Maternite Baudelocque, Paris; 1 Hopital 
Villeneuve-St-Georges. France 
The increasing frequency of ectopic pregnancy and the need of 
its early diagnosis have focused our interest on the research of 
biochemical markers. We have previously studied the profile of 
hCG, progesterone, and renin in fertile cycles after IVF-ET or 
GIFT and shown that his last parameter did not increase in 
ectopic pregnancies contrary to evolutive or abortive intrauterine 
pregnancies. After having established the hormonal value in the 
plasma of 99 spontaneous ongoing pregnancies between the 4th 
and 10th week of amenorrhea we have compared them to the 
values observed in 21 ectopic and 20 abortive pregnancies. The 
hCG levels are significantly higher in ongoing pregnancies but 
there is no statistically significant difference between abortive and 
ectopic gestation. The progesterone levels are significantly lower 
in ectopic pregnancies than in intrauterine gestation but are not 
really discriminant. The best parameter appears to be low active 
renin immunoradiometric assay (pasteur Diagnostic). The 
difference between ectopic pregnancy and evolutive or abortive 
intrauterine gestations is highly significant, the highest value 
corresponding to the 25th pecentile of normal values. The 
association of low hCG « 15000 Ul/ml) and low active renin (~ 
30 nglml) seems to be highly predictive of the ectopic pregnancy. 
The renin angiotensin system has an important role in the 
process of implantation, but an early signal could also be 
transmitted by the implanted embryo to the corpus luteum. 
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138. Tbe errect of polycblorinated Bipbenyls (PCB) 
on estradiol syntbesis of buman cumulus cells 
K. van der Ven, H. van der Ven, A. Thiebold, S. AI-Hasani, U. 
Wagner, K. Diedrich, and D. Krebs 
Department of Obstetrics and Gynaecology. University of Bonn. 
Bonn. Fed. Rep. of Germany 
Chlorinated hydrocarbons, E.G. PCBs, DDT, HCB, can be 
found in various body tissues and fluids. In human follicular fluid 
(n=10) we could determine the following concentrations of 
various PCB congeners (Ballschmitter nO 15, 118, 138, 153. 169, 
180) on estradiol synthesis of human cumulus cells was 
investigated. Cumulus cells were collected in an IVF programme 
and cultured in a modified Ham's FlO medium supplemented with 
5% fetal calf serum and 50 nglml 17P testosterone (cell 
concentration: 25000/ml. The PCB congeners were added in 
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concentrations between 0.1 and 1000 nglml. The concentration of 
estradiol was determined in the cell free supernatants after a 24 
hour culture period. All PCB congeners induced a dose dependent 
reduction of estradiol synthesis by human cumulus cells. The 
various PCB congeners showed different biological activities in 
regard to the inhibitory effect on estradiol secretion. A decrease of 
estradiol secretion could already be observed in PCB 
concentrations that correspond to the average load of human 
follicular fluid. 
139. Endocrine and immunological cbances in 
women witb cbronic wood preservative exposition 
I. Gerhard, M. Derner, B. Runnebaum 
Department of Gynaecological Endocrinology. Women's 
Hospital. University of Heidelberg. Heidelberg, F R.G. 
The influence of environmental pollution on human 
reproductive performance is unknown. The toxicity of 
organochlorine compounds (OC) was recongized following 
accidental poisoning. In animal studies OC administration 
resulted in a reduced number of pregnancies, and increased number 
of stillbirths. In the subsequent generation reduced fertility and 
chances in the menstrual cycle were noted. Wood preservatives 
containing various toxic OC are frequently used in industrialized 
states. Therefore it was the aim of this study to measure the 
pesticides pentachlorophenol (PCP) and 
gammahexachlorocyclohexane (Lindane, L) in women with 
hormonal disorders. In 22 out of 90 women examined elevated 
OC concentrations were found by capillary chromatography and 
masspectroscopy. PCP serum levels above 25 J.1g/l were judged 
elevated, as were L blood levels above 100 ngll. Elevated 
concentrations were found in 8 fertile women (6 of them with 
repeated abortions, aged 26-33 years), 8 women (aged 16 - 35 
years) with menstrual disorders and androgenisation symptoms, 
and 6 women (aged 42 - 56 years) with climacteric symptoms. 
The source of emmission was identified in the residence of each 
patient, the duration of exposure ranged from 2 to 20 years. 16 
women presented with adrenocortical malfunction (7 with 
hyperandrogenemia and 9 with partial adrenocorticoinsufficiency), 
15 with immunological disorders, 6 with thyroid gland 
dysfunction (1 with hyper- and 5 with hypothyroidism) and 3 
with luteal phase insufficiency. After elemination of the causative 
noxae and immunologic stimulation, blood OC concentrations 
decreased and the patients' physical conditions improved. 
menstruation normalized and, in case of conception, pregnancies 
resulted in healthy babies. On the basis of our data OC influence 
various hormonal systems including the adrenal and thyroid 
glands and reduce cellular immunity. Therefore an exact 
evaluation of environmental pollutions should be included in the 
endocrinological work-up of the patients with hormonal disorders 
and reproductive failure. 
140. Atrial natriuretic peptide (ANP) and 
progesterone in ovarian follicluar fluid 
E.A.P. Steegers, M. van Heeswijk, I.M.G. Hollanders, H.W. 
10ngsma, and P.R. Hein 
Department of Obstetrics and Gynaecology. University Hospital 
Nijmegen. The Netherlands 
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